Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American Journal of Physiology - Lung cellular and Molecular Physiology

• Publication date

  1999-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/ajplung.1999.276.5.L796PMID 10330036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice.

  1999cited by this paper
• Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection

  1999cited by this paper
• Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes.

  1998cited by this paper
• Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery

  1998cited by this paper
• Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery.

  1998cited by this paper
• In vivo expression of neutrophil inhibitory factor via gene transfer prevents lipopolysaccharide-induced lung neutrophil infiltration and injury by a beta2 integrin-dependent mechanism.

  1998cited by this paper
• Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA Complexes

  1998cited by this paper
• In Vivo Gene Transfer by Intravenous Administration of Stable Cationic Lipid/DNA Complex

  1997cited by this paper
• Peripheral blood mononuclear cells induce programmed cell death in human endothelial cells and may prevent repair: role of cytokines.

  1997cited by this paper
• CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.

  1997cited by this paper
• Pattern and Kinetics of Cytokine Production Following Administration of Phosphorothioate Oligonucleotides in Mice

  1997cited by this paper
• Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression.

  1997cited by this paper
• Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration

  1997cited by this paper
• Liposomal gene delivery: A complex package

  1997cited by this paper
• Spatial–temporal patterns of gene expression in mouse skeletal muscle after injection of lacZ plasmid DNA

  1997cited by this paper
• Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery

  1997cited by this paper
• Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation

  1997cited by this paper
• Promoter Attenuation in Gene Therapy: Interferon-γ and Tumor Necrosis Factor-α Inhibit Transgene Expression

  1997cited by this paper
• In vivo gene transfer via intravenous administration of cationic lipid–protamine–DNA (LPD) complexes

  1997influential reference
• Characterization of Cationic Liposome-Mediated Gene Transfer In Vivo by Intravenous Administration

  1997influential reference
• Basis of Pulmonary Toxicity Associated with Cationic Lipid-Mediated Gene Transfer to the Mammalian Lung

  1997cited by this paper
• Stabilization of cationic liposome‐plasmid DNA complexes by polyamines and poly(ethylene glycol)‐phospholipid conjugates for efficient in vivo gene delivery

  1997cited by this paper
• Improved DNA: liposome complexes for increased systemic delivery and gene expression

  1997cited by this paper
• Contribution of CpG motifs to the immunogenicity of DNA vaccines.

  1997cited by this paper
• Repression of retrovirus-mediated transgene expression by interferons: implications for gene therapy

  1997cited by this paper
• Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor‐α‐mediated shock

  1997cited by this paper
• Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.

  1996cited by this paper
• Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

  1996cited by this paper
• Direct gene transfer to mouse melanoma by intratumor injection of free DNA.

  1996cited by this paper
• IFN-gamma promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oligodeoxynucleotides.

  1996cited by this paper
• Synergy between Tumor Necrosis Factor α and Interleukin 1β in Inducing Transcriptional Down-regulation of Muscarinic M2 Receptor Gene Expression

  1996cited by this paper
• Synergy between tumor necrosis factor alpha and interleukin 1beta in inducing transcriptional down-regulation of muscarinic M2 receptor gene expression. Involvement of protein kinase A and ceramide pathways.

  1996cited by this paper
• CpG motifs in bacterial DNA trigger direct B-cell activation

  1995cited by this paper
• Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene.

  1994cited by this paper
• Systemic gene expression after intravenous DNA delivery into adult mice.

  1993cited by this paper
• DNA from Bacteria, but Not from Vertebrates, Induces Interferons, Activates Natural Killer Cells and Inhibits Tumor Growth

  1992cited by this paper
• Molecular cloning : a laboratory manual. Cold Spring Harbor, NY

  1989cited by this paper
• DNA methylation and its possible biological roles.

  1981cited by this paper

• COVID‐19 vaccine adverse events: Evaluating the pathophysiology with an emphasis on sulfur metabolism and endotheliopathy

  2024influential citation
• Application of Strontium Chloride Hexahydrate to Synthesize Strontium-Substituted Carbonate Apatite as a pH-Sensitive, Biologically Safe, and Highly Efficient siRNA Nanocarrier.

  2024cites this paper
• Effect of Lipid Nanoparticle Physico-Chemical Properties and Composition on Their Interaction with the Immune System

  2024cites this paper
• Exploiting a type III interferon response to improve chemotherapeutic safety and efficacy

  2024cites this paper
• The optimization strategies of LNP-mRNA formulations: Development and challenges for further application

  2024cites this paper
• Host Cell Restriction Factors Blocking Efficient Vector Transduction: Challenges in Lentiviral and Adeno-Associated Vector Based Gene Therapies

  2023cites this paper
• Reducing off-target drug accumulation by exploiting a type-III interferon response.

  2023cites this paper
• Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review

  2023cites this paper
• COVID-19 vaccine adverse events: Evaluating the pathophysiology from an undersulfated and degraded glycocalyx perspective

  2023cites this paper
• Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

  2022cites this paper
• The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-bearing Mice.

  2021cites this paper
• Virus Eradication and Synthetic Biology: Changes with SARS-CoV-2?

  2021cites this paper
• Lipid nanoparticles for mRNA delivery

  2021cites this paper
• Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors

  2020cites this paper
• Gene Therapy in Oncology

  2020cites this paper
• Cellular and molecular aspects of degenerative disc disease and potential strategies of biological therapy

  2020cites this paper
• An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells.

  2019cites this paper
• Localised non-viral delivery of nucleic acids for nerve regeneration in injured nervous systems.

  2019cites this paper
• A hepatic pDNA delivery system based on an intracellular environment sensitive vitamin E‐scaffold lipid‐like material with the aid of an anti‐inflammatory drug

  2018cites this paper
• Molecular Mechanisms and Biological Functions of siRNA

  2017cites this paper
• Advances in Non-Viral DNA Vectors for Gene Therapy

  2017cites this paper
• Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers

  2017cites this paper
• Preclinical Biodistribution and Safety Evaluation of a pbi-shRNA STMN1 Lipoplex after Subcutaneous Delivery

  2017cites this paper
• Current understanding of interactions between nanoparticles and the immune system.

  2016influential citation
• Self-assembled DNA/RNA nanoparticles as a new generation of therapeutic nucleic acids: immunological compatibility and other translational considerations

  2016cites this paper
• Shear stress increases cytotoxicity and reduces transfection efficiency of liposomal gene delivery to CHO-S cells

  2016cites this paper
• Enhanced gene delivery to the lung using biodegradable polyunsaturated cationic phosphatidylcholine-detergent conjugates.

  2016cites this paper
• Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design.

  2016cites this paper
• Interplay of Promoter Usage and Intragenic CpG Content: Impact on GFP Reporter Gene Expression

  2015cites this paper
• An investigation into persistent transgene expression from plasmid vectors in the lung

  2015cites this paper
• Strategy for selecting nanotechnology carriers to overcome immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics

  2015cites this paper
• RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.

  2015cites this paper
• PEGylated cationic nanoemulsions can efficiently bind and transfect pIDUA in a mucopolysaccharidosis type I murine model.

  2015cites this paper
• Design, Characterization and Application of Amphipathic Peptides for siRNA Delivery

  2013cites this paper
• Development and characterization of artificial viruses for gene therapy

  2013cites this paper
• Gene delivery platforms

  2013cites this paper
• PLGA (poly(D,L-lactic-co-glycolic)acid) particles as DNA carriers in Atlantic salmon (Salmo salar L.)

  2013cites this paper
• In vivo gene delivery with L-tyrosine polyphosphate nanoparticles.

  2013cites this paper
• Minimalistic immunologically defi ned gene expression T helper cell 1 (MIDGE-Th1 ® ) vectors coding for Inter- leukin 12 and -18 in combination with the transfection agent SAINT-18 have systemic antitumoral effects on equine melanomas

  2012cites this paper
• Retraction Note: A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium

  2012cites this paper
• Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development

  2012cites this paper
• Complexes of nucleolipid liposomes with single-stranded and double-stranded nucleic acids.

  2012cites this paper
• Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction.

  2012cites this paper
• RETRACTED ARTICLE: A novel method of augmenting gene expression and angiogenesis in the normal and ischemic canine myocardium

  2012cites this paper
• Nucleic-acid based gene therapeutics: delivery challenges and modular design of nonviral gene carriers and expression cassettes to overcome intracellular barriers for sustained targeted expression

  2012cites this paper
• Vectors for Inhaled Gene Therapy in Lung Cancer. Application for Nano Oncology and Safety of Bio Nanotechnology

  2012cites this paper
• The Potential and Challenges of siRNA-Based Targeted Therapy for Treatment of Patients with Glioblastoma

  2012cites this paper
• Nasal and Pulmonary Delivery of Macromolecules to Treat Respiratory and Nonrespiratory Diseases

  2012cites this paper
• Targeted Delivery to the Pulmonary Endothelium

  2012cites this paper
• Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors

  2012cites this paper
• Delivery Systems for Pulmonary Gene Therapy

  2012cites this paper
• Nucleus pulposus replacement and regeneration/repair technologies: present status and future prospects.

  2012cites this paper
• Supramolecular assemblies in functional siRNA delivery: where do we stand?

  2012cites this paper
• Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

  2012cites this paper
• Vaccination Strategies against Malaria: novel carrier(s) more than a tour de force.

  2012cites this paper
• Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic

  2011cites this paper
• Dendrosome-dendriplex inside liposomes: as a gene delivery system

  2011cites this paper
• Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics.

  2011cites this paper
• Inhibition of nuclear delivery of plasmid DNA and transcription by interferon γ: hurdles to be overcome for sustained gene therapy

  2011cites this paper
• Improving treatment outcomes in models of glioblastoma cancer

  2011cites this paper
• Hepatic Gene Therapy

  2011cites this paper
• Liver: A Major Target Organ in Gene Therapy

  2011cites this paper
• The significance of plasmid DNA preparations contaminated with bacterial genomic DNA on inflammatory responses following delivery of lipoplexes to the murine lung.

  2011cites this paper
• Safety of liver surface instillation of plasmid DNA in normal and carbon tetrachloride-induced hepatitis mice.

  2011cites this paper
• Antitumoral efficacy of DNA nanoparticles in murine models of lung cancer and pulmonary metastasis

  2010cites this paper
• CpG motifs in pDNA-sequences increase anti-PEG IgM production induced by PEG-coated pDNA-lipoplexes.

  2010cites this paper
• Prevention of hepatic ischemia-reperfusion injury by pre-administration of catalase-expressing adenovirus vectors.

  2010cites this paper
• TLR9 and IRF3 cooperate to induce a systemic inflammatory response in mice injected with liposome:DNA.

  2010cites this paper
• Palifermin induces alveolar maintenance programs in emphysematous mice.

  2010cites this paper
• BESCT (Biology, Education, Screening, Chemoprevention and Treatment) Program

  2010cites this paper
• Lipid-based systemic delivery of siRNA.

  2009cites this paper
• Gene and Cell Therapy for the Treatment of Cystic Fibrosis

  2009cites this paper
• Targeted Delivery of Nucleic Acid-Based Therapeutics to the Pulmonary Circulation

  2009cites this paper
• Pressure-Mediated Transfection of Murine Spleen and Liver

  2009influential citation
• Thérapie génique à l'aide de nanocapsules lipidiques PEGylées

  2009cites this paper
• Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression

  2009cites this paper
• The effects of salt on the physicochemical properties and immunogenicity of protein based vaccine formulated in cationic liposome.

  2009cites this paper
• Dendrimer nanocarriers as versatile vectors in gene delivery.

  2009cites this paper
• The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine

  2009cites this paper
• Evaluation of proinflammatory cytokine production and liver injury induced by plasmid DNA/cationic liposome complexes with various mixing ratios in mice.

  2009cites this paper
• Current prospects for mRNA gene delivery.

  2009cites this paper
• RNA interference for CFTR attenuates lung fluid absorption at birth in rats

  2008cites this paper
• Research paper Cationic lipid/DNA complexes induce TNF-a secretion in splenic macrophages

  2008cites this paper
• Cationic lipid/DNA complexes induce TNF-alpha secretion in splenic macrophages.

  2008cites this paper
• Plasmid CpG Depletion Improves Degree and Duration of Tumor Gene Expression After Intravenous Administration of Polyplexes

  2008cites this paper
• Innate immune response induced by gene delivery vectors.

  2008cites this paper
• Polyethylenimine-mediated gene delivery to the lung and therapeutic applications

  2008cites this paper
• Progress in developing cationic vectors for non-viral systemic gene therapy against cancer.

  2008cites this paper
• DiC14-amidine confers new anti-inflammatory properties to phospholipids

  2008cites this paper
• More trouble ahead; is gene therapy coming of age?

  2008cites this paper
• Systemic Delivery of DNA or siRNA Mediated by Linear Polyethylenimine (L-PEI) Does Not Induce an Inflammatory Response

  2008cites this paper
• Fibrin(ogen) - ein neuer Träger für nicht virale Genvektoren

  2008cites this paper
• Plastic Surgical Delivery Systems for Targeted Gene Therapy

  2008cites this paper
• Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice.

  2008cites this paper
• Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted

  2008cites this paper
• Biological treatment strategies for disc degeneration: potentials and shortcomings

  2007cites this paper
• Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system.

  2007cites this paper
• Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex.

  2007cites this paper
• Effects of Type I Interferons on the Adjuvant Properties of Plasmid Granulocyte-Macrophage Colony-Stimulating Factor In Vivo

  2007cites this paper
• Electroporation-mediated transfer of plasmids to the lung results in reduced TLR9 signaling and inflammation

  2007cites this paper